Navigation Links
Luminex Corporation Reports Fourth Quarter And Full Year 2012 Results
Date:2/4/2013

ww.luminexcorp.com.  Simply log on to the web at the address above, go to the Company section and access the Investor Relations link.  Please go to the website at least 15 minutes prior to the call to register, download and install any necessary audio/video software. If you are unable to participate during the live webcast, the call and slides will be archived for six months on the website using the 'replay' link.

Luminex develops, manufactures and markets proprietary biological testing technologies with applications throughout the life sciences industry.  The Company's xMAP system is an open-architecture, multi-analyte technology platform that delivers fast, accurate and cost-effective bioassay results to markets as diverse as pharmaceutical drug discovery, clinical diagnostics and biomedical research, including the genomics and proteomics research markets.  The Company's xMAP technology is sold worldwide and is in use in leading research laboratories as well as major pharmaceutical, diagnostic and biotechnology companies.  Further information on Luminex or xMAP can be obtained on the Internet at http://www.luminexcorp.com.

Statements made in this release that express Luminex's or management's intentions, plans, beliefs, expectations or predictions of future events are forward-looking statements. Forward-looking statements in this release include statements regarding: the expansion of our installed base; distribution for our instruments; purchases of our consumable products; the development progress and market acceptance of our assay products, including Gastrointestinal Pathogen Panel (GPP) and products developed and manufactured by Luminex Madison and Luminex Molecular Diagnostics; direct sales of our molecular diagnostic products to customers and transition from our distribution partners; FDA clearance of our products, including GPP, the acquisition of GenturaDx and the
'/>"/>

SOURCE Luminex Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Luminex Corporation Reports First Quarter 2012 Results
2. Luminex Corporation Announces Agreement to Acquire GenturaDx
3. Luminex Corporation Second Quarter Earnings Release Scheduled for July 30, 2012
4. Luminex Corporation Reports Second Quarter 2012 Results
5. Luminex Corporation and University Hospital of Wales Collaborate During Olympic Games
6. Luminex Corporation Awarded $11 Million Contract by Defense Threat Reduction Agency (DTRA)
7. Luminex Corporation Recognized as Best Technology Company in Austin
8. Luminex Corporation Hosts 10th Annual Planet xMAP Symposium in Monaco
9. Luminex Corporation To Present At Upcoming Investment Conferences In September
10. Luminex Corporation Reports Third Quarter 2012 Results
11. Luminex Corporation To Present At Leerink Swann Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... CHESTNUT RIDGE, N.Y. , March 6, 2015 ... it will host a conference call on Friday, ... review its results of operations for the fourth ... Par is privately held and currently makes certain ... filings with the Securities and Exchange Commission and ...
(Date:3/6/2015)... Del. , March 6, 2015 ... and Trademark Office,s publication of U.S. Patent Application ... Disorder."  The ,249 Patent Application features claimed methods of ... be used to treat Binge Eating Disorder (,BED,)," ... material," or "flyer or an advertisement," as well ...
(Date:3/5/2015)... 2015 BioLineRx (NASDAQ: BLRX ... to identifying, in-licensing and developing promising therapeutic candidates, ... public offering of American Depositary Shares ("ADSs"), each ... of the ADSs in the offering are to ... Securities is acting as sole book-running manager for ...
Breaking Medicine Technology:Lucerne Biosciences Announces Publication of Claimed Methods for Treating Binge Eating Disorder with Lisdexamfetamine Dimesylate 2BioLineRx Announces Underwritten Public Offering of its American Depositary Shares 2BioLineRx Announces Underwritten Public Offering of its American Depositary Shares 3
... Mich., June 15, 2011 Perrigo Company (Nasdaq: ... Industries Ltd. (Nasdaq: TEVA ) (previously Barr Laboratories ... Teva was the first applicant to file a complete ANDA ... be launching the product with 180 days of generic exclusivity. ...
... BRANFORD, Connecticut, June 15, 2011 , ... has killed dozens and,hospitalized thousands across Europe has been ... to generate the,"most accurate and detailed genetic analysis to ... ] ,The sequencing was performed by scientists at the ...
Cached Medicine Technology:Perrigo Announces Launch of the Generic Version of Nasacort® AQ 2Perrigo Announces Launch of the Generic Version of Nasacort® AQ 3Deadly E. Coli Strain Sequenced With Roche GS Junior System by HPA Scientists - Provides Community Most Complete Assembly to Date 2Deadly E. Coli Strain Sequenced With Roche GS Junior System by HPA Scientists - Provides Community Most Complete Assembly to Date 3
(Date:3/6/2015)... Angeles, CA (PRWEB) March 06, 2015 Los ... offering a special promotion for Zoom whitening. Zoom is a ... in a professional setting. Unlike other teeth whitening treatments, Zoom ... bright and free of stains. For a limited time, Dr. ... significant discount from the usual price of $650 and allows ...
(Date:3/6/2015)... Dr. Mark Sowell recently returned from leading a three day ... advanced education in the field of dentistry, Spear Education draws ... visiting faculty member of this prestigious institution, Dr. Sowell is ... Spear Education to participate in a specialized workshop. Of the ... the top 10% and those willing to sacrifice to be ...
(Date:3/6/2015)... 06, 2015 Medical Products, Inc., a ... agreement with GE Healthcare to become an authorized distributor ... States. , MPI has 31 years in distribution within ... , With this agreement, MPI will have the opportunity ... healthcare industry. , MPI has always strived to ...
(Date:3/6/2015)... The Public Health Accreditation Board (PHAB) ... seven more health departments. This week’s decisions by PHAB’s ... now be assured that their health departments demonstrate the ... communities. , Public health departments play a critical role ... communities. Across the nation, health departments provide a range ...
(Date:3/5/2015)... (PRWEB) March 06, 2015 In 2014, ... being first–in-class. AstraZeneca tops the list scoring 4 drug ... over 25% of all FDA approved drug products, followed ... mechanisms such as anti-PCSK9, anti-PD1 and CDK inhibitors keep ... approved by the FDA to treat metastatic melanoma, and ...
Breaking Medicine News(10 mins):Health News:Los Angeles Cosmetic Dentist, Dr. Poneh Ghasri, is Now Offering a Promotion on Zoom Whitening 2Health News:Plano Dentist Teaches Dentists from Around the Globe at Spear Education 2Health News:Nearly 113 Million U.S. Residents Now Reaping Benefits of National Public Health Department Accreditation 2Health News:Nearly 113 Million U.S. Residents Now Reaping Benefits of National Public Health Department Accreditation 3Health News:World Pharma Business and Large-Cap Companies Discussed by MP Advisors in In-demand Study Available at MarketPublishers.com 2Health News:World Pharma Business and Large-Cap Companies Discussed by MP Advisors in In-demand Study Available at MarketPublishers.com 3
... the consumption of fizzy soft drinks, according to a new ... have revealed that drinking the equivalent //of two cans of ... combat dementia in older people. ,Psychology lecturer ... for exams could benefit from increasing the amount of sugar ...
... Professor Susana Martinez-conde and her research team from Barrow Neurological ... movements occurring inside the eye even when the person ... proper visibility. ,Even when we are gazing at ... things visible and if these movement stops it leads to ...
... the country in question, Turkey has pointed out that its ... ,They say that those countries are hiding outbreaks of ... killed four Turkish children. ,In the words of the ... illness exists in our neighbouring countries which are ruled by ...
... for understanding the mechanism of joint motion and movement of ... as these are the regions which are mostly being used ... University of Florida is developing a robot which accurately detects ... they are working or walking. ,By understanding how ...
... Researchers at the University of North Carolina (UNC) at Chapel ... the lungs of patients affected by cystic fibrosis (CF). Hypertonic ... of the salt. ,The researchers arrived at this ... two weeks., They found that inhaling the salt solution improved ...
... marketing a single treatment malarial drug, by the World ... may develop a resistance to it. // ... that the practice of using artemisinin, one of the ... the parasite becoming resistant to the drug, and will ...
Cached Medicine News:
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: